Related by context. All words. (Click for frequent words.) 74 Evoltra 70 phase IIb trial 69 Evoltra R 69 Modrenal R 69 SNT MC# 69 Troxatyl 68 Icatibant 68 Firazyr 68 Vimpat ® lacosamide 68 Pirfenidone 68 Annamycin 68 lumiliximab 68 Clofarabine 68 TEMODAL 67 Aviptadil 67 clofarabine 67 IMA# 67 Evoltra ® 67 Rhucin R 67 Insegia 67 oxypurinol 67 Ceflatonin 67 Nexavar sorafenib 67 Amrubicin 67 Phase IIIb clinical 67 OvaRex ® MAb 66 orphan designation 66 thetreatment 66 Removab 66 BLA filing 66 Loramyc 66 KIACTA ™ 66 Raptiva R 66 Marketing Authorisation Application 66 Manja Bouman CEO 66 Mepact 66 lomitapide 66 Lupuzor 66 Trobalt 66 Esbriet 66 CDP# 66 Soliris TM eculizumab 66 CytoFab 65 Cloretazine 65 Loramyc R 65 OMAPRO ™ 65 Application MAA 65 Civacir 65 Canvaxin 65 Velcade bortezomib 65 phase IIb clinical 65 dexanabinol 65 Omapro 65 Alvesco R 65 EVIZON TM 65 Voraxaze 65 Marketing Authorization Application 65 Junovan 65 Zenvia ™ 65 dirucotide 65 SYCREST 65 hoFH 65 SEBIVO 65 Voraxaze ™ 65 Tracleer r 65 Noxafil 65 Kepivance 65 Firdapse 65 ATL# [001] 65 Fodosine 65 Dacogen injection 65 Proxinium TM 65 Onrigin 65 BrachySil TM 65 Brilique 65 Jevtana 65 AZILECT ® 65 Loramyc ® 65 Cetrorelix 64 YONDELIS 64 Certican 64 Angiox 64 Lambert Eaton Myasthenic 64 HuMax CD4 64 Zavesca r 64 Desmoteplase 64 histamine dihydrochloride 64 OMP designation 64 Cinryze ™ 64 rilonacept 64 Phase Ib study 64 Gleevec Glivec 64 Urocidin 64 Arranon 64 multiple myeloma MM 64 Revlimid lenalidomide 64 Personalized Immunotherapy 64 Angiox ® 64 Cinquil 64 CRMD# 64 ofatumumab 64 Sanvar R 64 Friedreich Ataxia FRDA 64 Troxatyl TM 64 amrubicin 64 Torisel 64 phase IIa clinical 64 BENLYSTA ® 64 forodesine 64 Raptiva ® 64 lucinactant 64 Fibrillex TM 64 bardoxolone 64 SCENESSE ® 64 Vectibix panitumumab 64 Plicera 64 elotuzumab 64 Zytiga 64 Pfizer Sutent 64 Clavis Pharma 64 investigational therapies 64 Increlex TM 64 pralatrexate 64 registrational 64 Rhucin 64 Erbitux cetuximab 64 mertansine 64 rALLy clinical trial 64 oral ridaforolimus 64 Clolar ® 64 terlipressin 64 drug ISA# 64 Sutent sunitinib 64 reslizumab 64 BEXXAR 64 tafamidis 63 methylnaltrexone 63 OHR/AVR# 63 Arzerra ofatumumab 63 acetonide FA 63 FOLOTYN ® 63 Ambrisentan 63 severe hypercholesterolemia 63 Preotact 63 adalimumab Humira 63 rasagiline tablets 63 Plenaxis R 63 Mozobil 63 Exherin TM 63 omacetaxine mepesuccinate 63 Allovectin 7 63 ZADAXIN ® 63 antibody MAb 63 LEVADEX ™ 63 gepirone ER 63 Uplyso 63 Joulferon 63 Orphan Status 63 RSR# 63 IND submission 63 TroVax ® 63 refractory CLL 63 CytoFabTM 63 vemurafenib 63 Orphan Drug status 63 Corlux 63 Cimzia TM 63 diabetic neuropathic pain 63 talactoferrin 63 enzastaurin 63 TYZEKA 63 Orphan Drug designation 63 ELACYT 63 Romiplostim 63 Ixempra 63 Tocosol Paclitaxel 63 CONBRIZA 63 Actimmune ® 63 SPRYCEL ® 63 MyVax ® 63 Provecta 63 Flutiform TM 63 Phase III TRIST 63 Adenuric R 63 alvespimycin 63 Folotyn 63 NP2 Enkephalin 63 ezogabine 63 Zingo TM 63 Torisel temsirolimus 63 atacicept 63 Phase Ib II 63 Trovax 63 Onconase 63 Oracea ® 63 Orphan Designation 63 IRESSA 63 refractory chronic lymphocytic 63 orphan medicinal product 63 Clolar 63 Bronchitol 63 Pazopanib 63 ELIQUIS 63 Orphan Drug Status 63 L BLP# 63 Abstral 63 relapsing remitting MS RRMS 63 Xanafide 63 Fabry Disease 63 ATPace TM 63 EGFR expressing mCRC 63 Soliris eculizumab 63 regorafenib 63 receptor tyrosine kinase inhibitor 63 omacetaxine 63 heterozygous FH 63 Firazyr ® 63 ruxolitinib 63 Vernakalant 63 Aflibercept 62 Mycograb 62 Allovectin 7 R 62 Syndrome LEMS 62 Peginterferon alfa 2b 62 Tykerb lapatinib 62 Tripep 62 tiapamil 62 relapsed multiple myeloma 62 Thalidomide Pharmion 62 recurrent herpes labialis 62 R sorafenib tablets 62 Junovan TM 62 ponatinib 62 Cardiac Cryoablation System 62 Receives Positive Opinion 62 IRX 2 62 thalidomide Thalomid 62 Aplidin 62 midstage trials 62 Altastaph 62 Orphan Drug Designation 62 NEBIDO 62 Ceflatonin R 62 #D#C# 62 TheraCIM 62 metastatic hormone refractory 62 Glassia 62 Nabi HB Intravenous 62 novel oral anticoagulant 62 UPLYSO 62 OMAPRO 62 Clinuvel 62 Fx #A 62 MabCampath 62 Oracea TM 62 Esbriet pirfenidone 62 ATG Fresenius S 62 Santhera 62 eritoran 62 DPX Survivac 62 deforolimus 62 TRISENOX 62 Phase IIa trial 62 WILEX 62 alemtuzumab Campath 62 CAELYX 62 docetaxel Taxotere R 62 ZOLINZA 62 Cloretazine ® 62 refractory acute myeloid 62 PrevOnco ™ 62 MAA submission 62 Sebivo 62 dirucotide MBP# 62 tramiprosate ALZHEMED TM 62 GTC recombinant human 62 Uvidem 62 palliative radiotherapy 62 eniluracil 62 herpetic keratitis 62 Tarceva TM 62 ACOMPLIA R 62 Archexin 62 Fibrin Pad 62 Tavocept 62 MGd 62 vosaroxin 62 Alemtuzumab 62 Increlex R 62 Cellegesic 62 Campath ® 62 Onalta 62 Marketing Authorization 62 Somatuline R Autogel R 62 Prestara 62 Initiates Enrollment 62 BioNumerik 62 Nexavar tablets 62 CHMP recommendation 62 StaphVAX 62 Viramidine 62 FIRAZYR 62 tamibarotene 62 Phase IIIb study 62 XIAFLEX ™ 62 Retacrit 62 Amigal 62 FRDA 62 Phase IIb trials 62 ularitide 62 vidofludimus 62 Rhucin ® 62 romidepsin 62 elacytarabine 62 pain palliation 62 Pivotal Phase III 62 vandetanib 62 Serdolect ® 62 PDE4 inhibitor 62 Tracleer R 62 GW# [003] 62 Combidex 62 FOLOTYN 62 Zeneus 62 Solasia 62 investigational humanized monoclonal antibody 62 Phase Ib clinical 62 relapsed leukemia 62 Davanat 62 Spiro Rombotis President 62 Cimzia ® certolizumab pegol 62 dasatinib Sprycel ® 62 Triapine 62 Deferiprone 62 MEPACT 62 Fortigel 62 Phase IIb clinical trials 62 Genasense ® 62 Sycrest 62 REMICADE ® 62 IV Busulfex 62 Multiferon R 62 RhuDex 62 acyclovir Lauriad R 62 Benlysta belimumab 62 Marketing Authorization Application MAA 62 FOR FURTHER INFORMATION ABOUT 62 anticancer compound 62 TroVax 61 AVASTIN 61 REPLAGAL 61 BAY #-# 61 molecular imaging radiopharmaceutical 61 XIAPEX 61 Prodarsan 61 sunitinib malate 61 etanercept Enbrel 61 Anturol TM 61 Phase Ib IIa 61 Yervoy 61 Phase #b/#a 61 JAK inhibitor 61 Telatinib 61 Keppra ® XR 61 Phenoptin 61 SUTENT ® 61 Genentech Roche 61 Octreotide 61 Pyridorin 61 CCR9 antagonist 61 HuMax TAC 61 PANVAC VF 61 Preotact R 61 BCR ABL inhibitor 61 Japanese Encephalitis vaccine 61 oral methylnaltrexone 61 ATryn R 61 Gleevec imatinib mesylate 61 alvimopan 61 Kuvan R 61 TRIST study 61 HQK 61 Vion Pharmaceuticals 61 PF # [002] 61 Mycamine 61 Somatuline Depot 61 Martin Nicklasson CEO 61 Stanate R 61 Ruconest 61 Aurograb 61 FDA Approvable Letter 61 Aryplase 61 IIa trial 61 vinflunine 61 Ceplene 61 eltrombopag 61 Ceplene histamine dihydrochloride 61 Mutual Recognition Procedure 61 MOZOBIL 61 metastatic sarcomas 61 Azilect ® 61 PDX pralatrexate 61 olaparib 61 cinacalcet HCl 61 MAGE A3 ASCI 61 intravenous iclaprim 61 Gencaro 61 Pixuvri 61 standard chemotherapy regimen 61 Allovectin 7 ® 61 Vernalis plc 61 Irinotecan 61 FIRMAGON R 61 Tracleer ® 61 Fibrillex 61 Treanda 61 Kynapid 61 Photocure 61 Nexavar ® 61 GED aPC 61 axitinib 61 midstage clinical 61 Eribulin 61 Tarceva erlotinib 61 XIAFLEX TM 61 Fludara ® 61 RhuDex ® 61 Vicinium TM 61 metastatic renal cell carcinoma 61 SinuNase TM 61 LUCASSIN 61 zanolimumab 61 Zybrestat 61 ThermoDox R 61 oral salmon calcitonin 61 velaglucerase alfa 61 MBP# [001] 61 Entocort 61 Egrifta 61 Zenpep 61 LymphoStat B TM 61 AA amyloidosis 61 Traficet EN 61 Toctino ® alitretinoin 61 Bayer Onyx 61 ixabepilone 61 Rituxan rituximab 61 Tostrex 61 Targretin capsules 61 Mipomersen 61 Increlex 61 pexiganan 61 Medicinal Products EMEA 61 mRCC 61 personalized immunotherapy 61 VitiGam 61 Phase 2b trial 61 Luveris 61 romiplostim 61 atypical Hemolytic Uremic Syndrome 61 cilengitide 61 PrevOnco 61 refractory gout 61 Rectogesic 61 maribavir 61 Bicifadine 61 sumatriptan DosePro 61 OPAXIO 61 Orathecin 61 Onco TCS 61 eprodisate KIACTA TM 61 cetuximab Erbitux 61 refractory APL 61 RoACTEMRA 61 TELINTRA 61 SIR Spheres 61 Rapinyl 61 Orphan designation 61 VALSTAR 61 interferon gamma 1b 61 lorvotuzumab mertansine 61 oral fludarabine 61 vernakalant hydrochloride 61 Golimumab 61 SNT-MC#/idebenone 61 bucindolol 61 RoActemra 61 AZILECT R 61 Alzhemed TM 61 Gaucher Disease 61 baminercept 61 refractory angina 61 Dacogen decitabine 61 MyVax 61 Omigard 61 Rescula 60 octreotide implant 60 ISTODAX 60 immune thrombocytopenic purpura ITP 60 MabThera Rituxan 60 silodosin 60 invasive candidiasis 60 Diamyd ® 60 Synvisc One 60 GI GVHD 60 Velaglucerase Alfa 60 TASKi3 60 recurrent glioblastoma multiforme 60 YONDELIS R 60 acute decompensated heart 60 HoFH 60 ospemifene 60 ONTAK 60 initiate Phase IIb 60 Orazol 60 StaphVAX R 60 bilastine 60 secondary hyperparathyroidism 60 Yondelis ® 60 malignant ascites 60 Octreolin 60 tramiprosate Alzhemed TM 60 Plenaxis 60 ONCASPAR 60 Pivotal Trial 60 ORENCIA R 60 CTAP# Capsules 60 Mylotarg 60 refractory acute promyelocytic 60 Saforis 60 Kit CD# positive 60 Rhucin ® recombinant 60 Zalbin 60 obatoclax 60 targeted radiotherapeutic 60 DXL# 60 Virulizin R 60 Xyrem ® 60 ORTHOVISC mini 60 mifamurtide 60 ThermoDox ® 60 Dupuytren Contracture 60 BEMA Fentanyl 60 Satraplatin 60 SAR# [004] 60 GRN# 60 Cancidas 60 Acute Radiation Syndrome ARS 60 gefitinib Iressa 60 ILUVIEN ® 60 Roche Actemra 60 Ventavis 60 Marketing Authorization Applications 60 Xeloda capecitabine 60 non metastatic osteosarcoma 60 CVac 60 AMEVIVE 60 BRILINTA 60 EFAPROXYN 60 Dermylex TM 60 phase IIa 60 OncoGel 60 Abiraterone acetate 60 Meets Primary Endpoint 60 oral prodrug 60 registrational trial 60 Behcet uveitis 60 Glybera R 60 Esbriet ® 60 Catena ® 60 abiraterone acetate 60 Cethrin 60 Certolizumab pegol 60 PI3K/Akt pathway inhibitor 60 Genentech Rituxan 60 XIAFLEX ® 60 HuMax EGFr 60 NOXAFIL 60 Silodosin 60 Hepatocellular Carcinoma HCC 60 Hedgehog antagonist 60 MyVax R 60 dalbavancin 60 Multiferon 60 incyclinide 60 Multiferon ® 60 MabThera rituximab 60 DAVANAT ® 60 Zavesca ® 60 bazedoxifene 60 indolent NHL 60 PREOS 60 JOULFERON 60 PROMACTA 60 Arzerra 60 relapsed refractory multiple myeloma 60 Degarelix 60 Enzyme Replacement Therapy 60 Pixantrone 60 StemEx R 60 LidoPAIN SP 60 Amgen Prolia 60 Receives Orphan Drug Designation 60 VPRIV 60 Tasimelteon 60 Marketing Authorisation 60 Iluvien ® 60 Phase #b/#a clinical 60 ProSavin 60 phase IIb study 60 Vilazodone 60 RELISTOR ® 60 PHX# 60 rindopepimut 60 EndoTAG TM -1 60 Hedgehog Pathway Inhibitor 60 Severe Sepsis 60 afamelanotide 60 albinterferon alfa 2b 60 glucocorticoid induced osteoporosis 60 faropenem 60 Febuxostat 60 MYLOTARG 60 Tasigna nilotinib 60 volociximab 60 SUTENT 60 generation purine nucleoside 60 Actemra tocilizumab 60 Hycamtin 60 eosinophilic asthma 60 trastuzumab DM1 60 sunitinib Sutent 60 lupus nephritis 60 Virulizin 60 immatics 60 pediatric acute lymphoblastic 60 Nebido 60 DPP4 inhibitor 60 ADVANCE PD 60 Begins Dosing 60 novel therapeutic antibodies 60 midstage studies 60 BENLYSTA 60 MEZAVANT 60 REBETOL combination therapy 60 DepoDur 60 initiate Phase 1b 60 PGL# 60 miconazole Lauriad 60 subcutaneous methylnaltrexone 60 Cimzia ® 60 oropharyngeal candidiasis OPC 60 Dynepo TM 60 Alimta pemetrexed 60 Zirgan 60 pradefovir 60 vaccine Synflorix 60 fostamatinib 60 Romidepsin 60 oxymorphone ER 60 Lumacan 60 HepeX B 60 EOquin TM 60 Pafuramidine 60 Generx ™ 60 Vascular Wrap TM 60 Orencia abatacept 60 Oncoscience AG 60 Myelodysplastic Syndrome MDS 60 MONOVISC 60 Vidaza azacitidine 60 Anidulafungin 60 pediatric Crohn disease 60 radiation sensitizer 60 Advagraf 60 Nicole Onetto MD 60 Ceplene TM 60 IL# PE#QQR 60 biologic therapy 60 OncoVex 60 Zenapax 60 FOSRENOL 60 FACTIVE R gemifloxacin 60 Plenaxis TM 60 idiopathic pulmonary fibrosis IPF 60 Rilonacept 60 ZEVALIN ® 60 Orphan Medicinal Product 60 tanespimycin 60 IAP inhibitors 60 Surfaxin LS 60 opioid induced bowel dysfunction 60 Azedra 60 neratinib 60 investigational antiplatelet agent 60 Theratope 60 lymphoma CTCL 60 Gattex 60 ARIXTRA R 60 Xerecept 60 TORISEL 60 Zebinix R 60 Pegloticase 60 Cinryze TM 60 cutaneous T 60 Hervé Hoppenot President 60 Cx# [002] 60 Panzem R 60 Initiates Clinical 60 Factor Xa inhibitor 60 Humira adalimumab 60 ELAPRASE 60 Vasovist 60 Lu AA# 60 relapsing multiple sclerosis 60 TOCOSOL Camptothecin 60 sitaxsentan sodium 60 ketolide antibiotic 60 systemic fungal infections 60 macitentan 60 Toctino R 60 palifermin 60 proteasome inhibitor 59 FlutiformTM 59 Daclizumab 59 Neupro R 59 LPLD 59 Omacetaxine 59 SEPET TM 59 RSD# oral 59 Hexvix ® 59 depsipeptide 59 Gleevec imatinib 59 rhIGF-I/rhIGFBP-3 59 P#X# antagonist 59 pafuramidine 59 miconazole MBT 59 OvaRex R 59 Campath alemtuzumab 59 docetaxel Taxotere ® 59 apricitabine ATC 59 candidates Dyloject TM 59 successfully commercialize Iluvien 59 transfusional iron overload 59 Marqibo 59 Ilaris 59 bendamustine 59 CIMZIA r 59 Initiates Phase III 59 UCB Cimzia 59 CoFactor 59 Increlex ® 59 Ranolazine 59 confirmatory Phase III 59 liprotamase 59 Frova ® 59 Shigamabs ® 59 Mirapexin 59 MAXY alpha 59 Potelligent Technology 59 EGRIFTA TM 59 Ceflatonin ® 59 QuadraSphere 59 Cloretazine R VNP#M 59 Cladribine Tablets 59 Advexin 59 Bayer Nexavar 59 REVLIMID 59 p# inhibitor 59 IMiDs 59 HuLuc# 59 nalbuphine ER 59 sorafenib Nexavar 59 Bezielle 59 RIGScan CR 59 ASA# 59 BrachySil 59 Eraxis 59 PDE# inhibitors 59 trabectedin 59 Onalta ™ 59 AEG# 59 candidate epratuzumab 59 anti angiogenic agents 59 hereditary deficiency 59 Unit Dose Budesonide 59 including eniluracil ADH 59 supplemental biologics 59 Toctino ® 59 Augment Injectable 59 subcutaneous formulation 59 SUMAVEL DosePro 59 Teysuno 59 IV APAP 59 MKC# MT 59 Bioral Amphotericin B 59 G#DT 59 Completes Patient Enrollment 59 delivers fluocinolone acetonide FA 59 huC# DM4 59 TREANDA 59 Oasmia 59 SinuNase 59 mesylate tablets approved 59 rThrombin 59 GALNS 59 Forsteo 59 orBec 59 heavily pretreated 59 cSSTI 59 Lilly Gemzar 59 cytotoxic therapy 59 Avastin bevacizumab 59 SYGNIS 59 TRACON Pharmaceuticals 59 Viprinex TM 59 investigational monoclonal antibody 59 Ganciclovir 59 Sylvie Gregoire President 59 atherothrombotic events 59 Pertuzumab 59 Prosaptide 59 Cimzia certolizumab pegol 59 Diabetic Macular Edema 59 frovatriptan 59 Zolinza 59 Zemiva TM 59 IPLEX 59 Asentar 59 Vimpat R 59 oral deforolimus 59 Alvesco ® 59 lintuzumab SGN 59 balsalazide tablet 59 XIAPEX ® 59 multicenter Phase II 59 OSI Tarceva 59 ARIKACE ™ 59 Merck KGaA Erbitux 59 Cutanea 59 apricitabine 59 Motavizumab 59 Dyloject TM 59 pitavastatin 59 Azacitidine 59 ZACTIMA 59 Oxaliplatin 59 ocrelizumab 59 PXD# 59 Eliquis 59 Zerenex 59 panitumumab Vectibix 59 RH1 59 Centralized Procedure 59 Valtropin 59 Extavia 59 BRIM3 59 phase Ib 59 clinical pharmacology studies 59 Lodotra 59 taliglucerase alfa 59 Fenoglide 59 IMC A# 59 Nanobody R 59 retigabine 59 CEQ# 59 Prepandrix 59 anidulafungin 59 intravenous acetaminophen 59 aerosolized AAT 59 PregLem 59 GV# [001] 59 efaproxiral 59 Panzem 59 SANVAR 59 Emezine 59 kidney urologic 59 Syntonix 59 Sudhir Agrawal D.Phil 59 Phase 2a trial 59 cutaneous T cell 59 liver resection surgeries 59 ADVEXIN p# therapy 59 tetrabenazine 59 biliary tract cancer 59 Vascugel 59 Zensana 59 Loramyc ™ 59 Ustekinumab 59 daclizumab 59 Aurexis 59 rufinamide 59 oropharyngeal candidiasis 59 metaglidasen 59 aztreonam lysine 59 TNF inhibitor therapy 59 DEB# 59 Thelin tm 59 Initiates Phase II 59 Viprinex 59 hyperphosphataemia 59 ASONEP 59 Navelbine ® 59 commercialize oritavancin 59 Mantle Cell Lymphoma 59 LHRH antagonist 59 Vibativ 59 prGCD 59 Gelclair 59 post herpetic neuralgia PHN 59 PRT# 59 NeuVax 59 adult chronic ITP 59 Oglemilast 59 Dendreon Provenge 59 POSIDUR TM 59 AQ4N 59 tramiprosate 59 bortezomib Velcade 59 TBC# 59 BioSTAR R 59 Sprycel dasatinib 59 budiodarone 59 naronapride 59 castrate resistant prostate cancer 59 Fast Track Status 59 personalized cellular immunotherapy 59 Genz # 59 STELARA TM 59 Prodarsan R 59 Kamada AAT 59 systemic ALCL 59 ganetespib 59 Initiate Clinical Trial 59 KRN# 59 recurrent NSCLC 59 LEUKINE 59 Proquin XR 59 esophageal candidiasis 59 panitumumab 59 GTC recombinant form 59 pseudobulbar affect PBA 59 Inc. Nasdaq NLTX 59 chronic ITP patients 59 Loramyc TM 59 IMC #F# 59 Submits Response 59 relapsed ALL 59 markets HP Acthar 59 Aloxi R 59 oxaliplatin Eloxatin 59 carfilzomib 59 rheumatoid arthritis psoriatic arthritis 59 lymphoid malignancies 59 nosocomial pneumonia 59 TAXUS Element Stent System 59 anti inflammatory NSAID 59 radiotherapeutic 59 postoperative ileus POI 59 Oral lyn 59 mapatumumab 59 BLA submission 59 Mitoxantrone 59 OncoVEX 59 virus HCV protease inhibitor 59 Teflaro 59 erlotinib Tarceva 59 OMNARIS HFA 59 diarrhea predominant irritable 59 faropenem medoxomil 59 ADVEXIN 59 Cloretazine R 59 refractory metastatic colorectal cancer 59 Phase IIb trial 59 ALN PCS 59 Veronate 59 Somatuline R Depot 59 Perforomist ™ Inhalation Solution 59 CAMPATH R 59 Aggrastat 59 CHMP opinion 59 CIP TRAMADOL ER 59 MKC# MKC# PP 59 PNP inhibitor 59 submitted Marketing Authorization 59 oral antiplatelet agent 59 mipomersen 59 Panitumumab 59 dermatology biopharmaceutical company 59 Urocidin TM 59 Æterna Zentaris 59 riociguat 59 aflibercept VEGF Trap 59 Lovaza TM 59 pharmacokinetic PK study 59 ambrisentan 59 ONCONASE 59 Hematide ™ peginesatide 59 Fablyn